nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Ageing widows in India
|
Merten, Martina |
|
|
405 |
10489 |
p. 1570-1571 |
artikel |
2 |
CONSORT 2025 statement: updated guideline for reporting randomised trials
|
Hopewell, Sally |
|
|
405 |
10489 |
p. 1633-1640 |
artikel |
3 |
Department of Error
|
|
|
|
405 |
10489 |
p. 1579 |
artikel |
4 |
Department of Error
|
|
|
|
405 |
10489 |
p. 1579 |
artikel |
5 |
Durability and efficacy of solbinsiran, a GalNAc-conjugated siRNA targeting ANGPTL3, in adults with mixed dyslipidaemia (PROLONG-ANG3): a double-blind, randomised, placebo-controlled, phase 2 trial
|
Ray, Kausik K |
|
|
405 |
10489 |
p. 1594-1607 |
artikel |
6 |
Gene therapy approval for Duchenne muscular dystrophy: a European perspective
|
Jolly, Hannah |
|
|
405 |
10489 |
p. 1572-1573 |
artikel |
7 |
Gene therapy: who should decide the Deaf community's future
|
Lichy, Tom |
|
|
405 |
10489 |
p. 1577-1578 |
artikel |
8 |
Gepotidacin shows promise for the treatment of uncomplicated gonorrhoea
|
Unemo, Magnus |
|
|
405 |
10489 |
p. 1560-1562 |
artikel |
9 |
Health service crisis in Lebanon: Hezbollah is the problem
|
Turnberg, Leslie |
|
|
405 |
10489 |
p. 1577 |
artikel |
10 |
Increasing walking capacity in patients with peripheral artery disease
|
Beckman, Joshua A |
|
|
405 |
10489 |
p. 1556-1557 |
artikel |
11 |
Iscalimab 600 mg: justified or excessive?
|
Ho, Yi-Yu |
|
|
405 |
10489 |
p. 1578 |
artikel |
12 |
Iscalimab 600 mg: justified or excessive? – Authors' reply
|
Fisher, Benjamin A |
|
|
405 |
10489 |
p. 1578-1579 |
artikel |
13 |
Measles: the urgent need for global immunisation and preparedness
|
Kuppalli, Krutika |
|
|
405 |
10489 |
p. 1565-1567 |
artikel |
14 |
Oral gepotidacin for the treatment of uncomplicated urogenital gonorrhoea (EAGLE-1): a phase 3 randomised, open-label, non-inferiority, multicentre study
|
Ross, Jonathan D C |
|
|
405 |
10489 |
p. 1608-1620 |
artikel |
15 |
Primary health care on the ballot in Australian election
|
Cousins, Sophie |
|
|
405 |
10489 |
p. 1568-1569 |
artikel |
16 |
Prolonged grief disorder
|
Killikelly, Clare |
|
|
405 |
10489 |
p. 1621-1632 |
artikel |
17 |
Rebuilding Syria's mental health system after decades of war
|
Ahmed, Darya Rostam |
|
|
405 |
10489 |
p. 1575 |
artikel |
18 |
Resilience amid ruins: the silent screams and steadfast spirit of Syria
|
Hanifa, Hamdah |
|
|
405 |
10489 |
p. 1575-1576 |
artikel |
19 |
Revisiting the issue of female genital reinfibulation in HICs
|
Bonavina, Giulia |
|
|
405 |
10489 |
p. 1573-1574 |
artikel |
20 |
Semaglutide and walking capacity in people with symptomatic peripheral artery disease and type 2 diabetes (STRIDE): a phase 3b, double-blind, randomised, placebo-controlled trial
|
Bonaca, Marc P |
|
|
405 |
10489 |
p. 1580-1593 |
artikel |
21 |
The need to call out corporate corruption in health
|
Walls, Helen |
|
|
405 |
10489 |
p. 1562-1564 |
artikel |
22 |
The pandemic treaty: a milestone, but with persistent concerns
|
The Lancet, |
|
|
405 |
10489 |
p. 1555 |
artikel |
23 |
Therapy for mixed dyslipidaemia through ANGPTL3 inhibition
|
Santos, Raul D |
|
|
405 |
10489 |
p. 1558-1559 |
artikel |
24 |
Towards trust and equity: Syria's health system reform
|
Zoukar, Imad |
|
|
405 |
10489 |
p. 1576-1577 |
artikel |